Cart
sales@molnova.com
SGI-7079
CAS No. 1239875-86-5
SGI-7079( SGI-7079 | SGI 7079 | SGI7079 )
Catalog No. M17214 CAS No. 1239875-86-5
SGI-7079 is a new selective Axl inhibitor. SGI-7079 can be a dose-dependent manner inhibited growth of tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 118 | In Stock |
|
| 25MG | 259 | In Stock |
|
| 50MG | 374 | In Stock |
|
| 100MG | 501 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSGI-7079
-
NoteResearch use only, not for human use.
-
Brief DescriptionSGI-7079 is a new selective Axl inhibitor. SGI-7079 can be a dose-dependent manner inhibited growth of tumors.
-
DescriptionSGI-7079 is a potent and selective Axl inhibitor with potential anticancer activity. SGI-7079 effectively inhibited Axl activation in the presence of exogenous Gas6 ligand. SGI-7079 inhibited tumor growth in a dose dependent manner. Axl is a potential therapeutic target for overcoming EGFR inhibitor resistance.
-
In Vitro——
-
In Vivo——
-
SynonymsSGI-7079 | SGI 7079 | SGI7079
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorMet| RET| FLT3| Yes| AXL| Mer
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1239875-86-5
-
Formula Weight455.53
-
Molecular FormulaC26H26FN7
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 34 mg/mL. 74.64 mM
-
SMILESCN1CCN(CC1)c1ccc(Nc2nc3c(c(C)c[nH]3)c(n2)c2cc(CC#N)ccc2)cc1F
-
Chemical Name2-(3-(2-((3-fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)acetonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Myers SH, et al. J Med Chem. 2016, 59(8):3593-608.
molnova catalog
related products
-
Casein kinase 1δ-IN-...
Casein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.
-
SSTC3
SSTC3 is a novel small-molecule CK1α activator with EC50 of 30 nM (WNT-driven reporter gene assay), Kd of 32 nM.
-
(R)-DRF053 dihydroch...
(R)-DRF053 dihydrochloride (DRF053)?is a potent, cell-permeable, dual CK1/CDK inhibitor with IC50 of 14 nM, 220 nM and 80 nM for CK1, CDK5/p25 and CDK1/cyclin B, respectively.
